Caring for you through prevention, detection and treatment of cardiovascular disease
For more than 25 years, Baylor Scott & White The Heart Group has had a strong commitment to offering advanced cardiac care and personal service to our patients, our referring physicians and our community. The skilled heart care physicians here stay on the forefront of medical breakthroughs, working hard to offer you effective and appropriate treatments to help you live a longer, healthier life.
We believe in partnering with our patients and their primary care physicians to facilitate open communication and well-informed medical decisions. We are dedicated to helping you take charge of your health through:
- Prevention—medications, and lifestyles
- Detection—advanced testing
- Treatment—minimally invasive options
Baylor Scott & White has established agreements with several types of insurance to ensure your health needs are covered.
Aetna - (2)Aetna Signature AdministratorsMedicare Advantage Plans
Blue Cross Blue Shield - (9)Blue EssentialsBlue PremierParPlanBlue Advantage HMOBlue Choice PPOBlue Premier Open Access HMOMedicare Advantage - OncorTraditionalIndemnity
Cigna - (4)LocalPlusOpen Access PlusChildren's Medical Center Employee PlanCity of Dallas Employee Plan
DFW ConnectedCare - (1)American Airlines Employee Benefit Plan
HealthSmart - (2)ACCEL NetworkPreferred Network
Humana - (4)ChoiceCareHumana PreferredNational POSCommercial PPO Plans
Superior Health Plan - (1)STAR+PLUS
Superior HealthPlan - (3)STAR+PLUSMedicare/Medicaid Dual Needs Plan: Advantage HMO SNPMedicare/Medicaid Plan
Healthscope - (2)DART ACO FlexDART ACO Flex Plus
Parkland Community Health Plan - (2)CHIP MedicaidHealthFirst Medicaid
Scott & White Health Plan - (14)HMO Network - Individual/FamilyEPO Network - Individual/FamilySeniorCare Advantage HMOSeniorCare Advantage PPOHMO Network - GroupTRS - Active Care Participants NetworkPPO Network - GroupPPO Choice NetworkPPO Choice Preferred NetworkCigna PPO Network - Out-of-Area Member PlanTexas Statewide PPOPHCS/ARGUS - PPO Network - Out-of-Area Member PlanEPO Network - GroupMcLane Group Network
UnitedHealth - (2)Nexus ACO OANexusACO R
University Mary Hardin-Baylor - (1)Employee Benefit Plan
We couldn’t find any results for ""
Hospital services and procedures
We continually strive to improve the quality of life for our heart patients by providing recent diagnostic advances in technology and allowing for a less-invasive experience in the detection of cardiovascular disease.
- Transesophageal echocardiography (TEE)
- CT angiography (CTA)
- Cardiac MRI
- PET scan
- Cardiac catheterization
- Coronary artery imaging
- Endomyocardial biopsy; post-cardiac Transplant
- Coronary intravascular ultrasound
- Percutaneous coronary angioplasty and coronary artery stenting
- Coronary artery atherectomy (laser and rotational)
- Congenital anomaly repairs
- ASD closure
- Left ventricular assist device (LVAD) insertion
- IVC filter placement
- Cardiac Rhythm Management
- Permanent pacemaker implants
- Biventricular pacemaker implants
- Internal cardioverter-defibrillator implants
- Aortic aneurysm stenting
- Carotid artery stenting
- Carotid angiography
- Peripheral percutaneous transluminal angioplasty (PTA)
- Renal percutaneous transluminal angioplasty (PTA)
- Peripheral artery atherectomy (laser and rotational
Office services and procedures
We offer procedures that can be done right in the comfort of our office—like testing for carotid stenosis, abdominal aortic aneurysm and peripheral arterial diseases. Our goal is to develop a strategy of diagnosis and treatment that is right for each individual with the best possible outcome.
- Stress echocardiogram
- Exercise stress test
- Pharmacological stress test
- Holter monitor/Event monitor
- BioZ (evaluation of cardiac function)
- Nuclear stress test
- Adenosine nuclear test (Pharmacological)
Vein Treatment Center
- EVLT (endovenous laser treatment) for varicose veins
- Carotid artery ultrasound
- Vascular studies
- Aortic aneurysm screening
Baylor Scott & White Health is pleased to offer you multiple options to pay your bill. View our guide to understand your Baylor Scott & White billing statement.
Other payment options:
At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a team member before, during or after care is received.
To ensure that your visit to our office is as convenient and efficient as possible, we are pleased to offer our registration forms online. The patient registration form may be completed electronically and printed for better legibility or completed manually.
In clinic and hospital settings, research trials are performed with patients who generously give physicians, and those in the cardiovascular research and healthcare industry, the opportunity to further study cardiovascular disease. The cardiologists at Baylor Scott & White The Heart Group have been active in research for over 20 years, advancing new prevention and treatment options for our patients. These studies are vital and allow us to provide innovative treatments to our patients who are involved in these investigative trials. We are grateful to our patients who take part in them.
Why do we participate in clinical trials?
Our physicians believe that by studying new medications and treatment options for cardiovascular disease, they will be able to offer progressive medical care to their patients.
What criteria must the patient meet to participate in a trial?
Each clinical study has specific criteria which the patient must meet. These guidelines relate to the patient’s condition and determine whether he/she is qualified to participate. If considering whether to participate in a study or not, it is best to speak with your physician about any concerns or questions you may have.
If you have a heart-related condition and would like to participate in a trial, speak with your Baylor Scott & White The Heart Group cardiologist first.
Pioneer II - The Pioneer II study is an open-label, tandomized, controlled, multicenter study exploring two treatment strategies of Rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention: PIONEER AF-PCI.
Sur-TAVI - Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement.
PVL in TAVR - A Novel Imaging Approach to Assess Paravalvular Leak for Transcatheter Valve Replacement.
Low Dose CT - A Novel Low-dose-contrast Cardiac Computed Tomography Method for Pre-Procedural Guidance in Transcatheter Aortic Valve Replacement.
ABSORB - Resorbable coronary stent-Brown
ISCHEMIA - To determine the best management strategy for patients with stable ischemic heart disease (SIHD) and moderate-to-severe ischemia; routine early invasive strategy (INV) with cardiac catheterization (cath) followed by revascularization plus optimal medical therapy (OMT) is superior to a conservative strategy (CON) of OMT.
SYMPLICITY - Renal denervation for uncontrolled hypertension.
STOP AF PAS - Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)-Gopal
PARTNER II - Placement of Aortic Transcatheter Valves Trial. The Safety and Effectiveness of the SAPIEN XT™ Transcatheter Heart Valve with Novaflex and Ascendra 2 delivery systems (Transfemoral and Transapical) in Intermediate Risk for Aortic Valve Surgery and Patients Who Cannot Undergo Surgery.
Resolute Integrity - A Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm
EXCEL - Evaluation of XIENCE PRIME or XIENCE V versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
COAPT - Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for High Surgical Risk Patients.
EVOLVE II Trial - The purpose of this study is to assess the safety and effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System for the treatment of subjects with atherosclerotic lesion(s) ≤ 34 mm in length (by visual estimate) in native coronary arteries ≥2.25 mm to ≤4.0 mm in diameter (by visual estimate).
CTOT II Trial - is an investigative consortium for conducting clinical and associated mechanistic studies that will lead to improved outcomes for transplant recipients. The purpose of these studies is to improve short and long-term graft and patient survival.
PORTICO - is a prospective, multi-center, randomized-controlled clinical study, designed to evaluate the safety and effectiveness of the St. Jude Medical (SJM) Portico Transcatheter Heart Valve and Delivery Systems (Portico) via the transfemoral and transapical delivery methods, in high and extreme risk cohorts.
Direct Flow - is a study to assess the safety and effectiveness of the Direct Flow Medical aortic valve system. This is for people with severe aortic stenosis who are not well enough to undergo a surgical repair.
News and media
Tips for managing heart health
Heart disease is the leading cause of death in the United States. Dr. Deepika Gopal provides valuable tips for heart health.
Aortic stenosis treatment options
International Heart Valve Conference bolsters Dallas' profile
Dallas- Leipzig Valve 2012 Conference - Dallas has quietly become the U.S. showcase for innovative heart valve techniques.